España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Wellbeing Digital
KONEF
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.000010
At close: Dec 10, 10:43 AM EDT
Get Report
Comment
Wellbeing Digital (KONEF) Forecast
News
Earnings
Wellbeing Digital (KONEF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Wellbeing Digital (OTC:KONEF) Stock
Wellbeing Digital Stock (OTC: KONEF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, June 26, 2023
World's Largest Psychedelics Conference Sheds Light On Alternative Mental Health Therapies, Boasts 12K Attendees
Lara Goldstein
Monday, March 13, 2023
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
Lara Goldstein
Thursday, March 09, 2023
Another Company Approved To Begin Production Of Psychedelics Under Canadian Dealers License
Lara Goldstein
Wednesday, March 08, 2023
Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
Lara Goldstein
Tuesday, February 21, 2023
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Lara Goldstein
Tuesday, February 14, 2023
Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder
Lara Goldstein
Monday, January 30, 2023
Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers
Lara Goldstein
Tuesday, December 27, 2022
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
Lara Goldstein
Tuesday, December 06, 2022
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Lara Goldstein
Thursday, December 01, 2022
EXCLUSIVE: MAPS To Host Major Psychedelics Event In 2023, Speakers & Details Below
Lara Goldstein
Wednesday, November 30, 2022
Psychedelic Partnership To Test Psilocybin For FXS In First Phase 2 Clinical Trial
Lara Goldstein
Tuesday, November 22, 2022
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Lara Goldstein
Thursday, November 17, 2022
Psychedelics For FXS Symptoms: New Research Contract For Upcoming Phase 2 Clinical Trial
Lara Goldstein
Tuesday, November 15, 2022
Successful Study On Transdermal CBD & THC Delivery Presents Benefits For Treating Chronic Conditions
Joana Scopel
Tuesday, November 01, 2022
Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More
Lara Goldstein
Thursday, October 27, 2022
Pathway Health To Acquire IRP Health From Wellbeing Digital Sciences
Vuk Zdinjak
Friday, October 07, 2022
Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More
Lara Goldstein
Wednesday, October 05, 2022
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
Lara Goldstein
Friday, September 16, 2022
Wellbeing Digital Reports 4Q Finances, 'Three Key Pillars' Stay Strong
Lara Goldstein
Tuesday, August 30, 2022
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
Lara Goldstein
Thursday, July 21, 2022
KGK Sciences And Halucenex Sign Contract For Phase II Clinical Trial On Psilocybin For PTSD
Lara Goldstein
Monday, July 18, 2022
Wellbeing Digital Introduces Women In Psychedelics, A Network For Female Minds In Psychedelics
Lara Goldstein
Friday, March 18, 2022
Wellbeing Digital Net Loss Continues To Grow: Q2 Reaches $5.15M, Up By 552% YoY
Vuk Zdinjak
Tuesday, March 15, 2022
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, March 14, 2022
Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, March 07, 2022
Psychedelic Stock Gainers And Losers From March 7, 2022
Benzinga Insights
Friday, March 04, 2022
Psychedelic Stock Gainers And Losers From March 4, 2022
Benzinga Insights
Tuesday, March 01, 2022
Psychedelic Stock Gainers And Losers From March 1, 2022
Benzinga Insights
Monday, February 28, 2022
Psychedelic Stock Gainers And Losers From February 28, 2022
Benzinga Insights
Monday, February 14, 2022
Psychedelic Stock Gainers And Losers From February 14, 2022
Benzinga Insights
Tuesday, February 08, 2022
Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market
Rachael Green
-
Sponsored
Thursday, January 27, 2022
Wellbeing Digital Sciences' Subsidiary KGK Science Forms Tactical Partnership With Nova Mentis
Wellbeing Digital Sciences
-
Sponsored
Tuesday, January 18, 2022
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
Natan Ponieman
Wednesday, January 12, 2022
Ketamine One Shares Uplisted To OTCQB
Aaron Bry
Wednesday, December 15, 2021
Cannabis Movers & Shakers: HEXO, Agrify, MindMed, KetamineOne
Jelena Martinovic
Friday, December 10, 2021
Cannabis Dispensary Roundup: Verano, Jushi, Cresco, KetamineOne
Jelena Martinovic
Monday, November 22, 2021
Cannabis Dispensary Roundup: Ascend Wellness, Ketamine One, Cresco, Kiaro, TILT, BELLEBUD
Jelena Martinovic
Monday, October 18, 2021
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Natan Ponieman
Wednesday, October 13, 2021
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Natan Ponieman
Monday, September 27, 2021
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
Natan Ponieman
Monday, August 30, 2021
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Natan Ponieman
Monday, August 23, 2021
KetamineOne Capital Forms Medical Advisory Board, Will Oversee Development Of Its Mental-Health Platform
Nina Zdinjak
